World Video | Defence | Foreign Affairs | Natural Events | Trade | NZ in World News | NZ National News Video | NZ Regional News | Search

 


Testing for Counterfeit Drug Tool Screening Begins in Africa

Field Testing for Rapid Counterfeit Drug Screening Tool Begins in Africa

Initial testing targets ability to identify fake & poor quality malaria medicines

Rockville, Md., June 4, 2014 — Field testing for a new screening tool intended to help quickly detect counterfeit and poor quality medicines has begun at the U.S. Pharmacopeial Convention’s (USP) Center for Pharmaceutical Advancement and Training (CePAT), located in Ghana.

The new screening device, called CD-3+, was launched by the U.S. Food and Drug Administration in April 2013.

“CD-3+ is, rapid, portable device that requires little training for effective use, potentially changing the way counterfeit and poor quality products are detected and resulting in substantial cost savings over more expensive alternatives,” says Patrick Lukulay, Ph.D., vice president of Global Health Impact Programs at USP and director of the Promoting the Quality of Medicines program (PQM). “The testing now underway in Ghana will provide a side-by-side comparison of CD-3+ with other existing screening devices to assess the capability to discriminate between authentic and substandard medicines.”

Specifically, the tests conducted in the field and at CePAT will evaluate CD-3+ in the screening of two malaria treatments commonly used in Sub-Saharan Africa. A total of 200 test samples are being collected from sites across Ghana through acollaborative partnership between USP and the Ghana’s Food and Drug Authority. Results from the first field study are expected in September 2014.

“Field tests such as these will not only help us determine complementary advantages of the tools under evaluation, but will also help identify potential design improvements to CD-3+ to enable the development of a more robust, more portable and even easier to use tool,” says Leigh Verbois, director, Asia Pacific Office, Office of International Programs at U.S. FDA.

The U.S. FDA was responsible for training personnel on how to properly use CD-3+ at CePAT and other test sites.

Testing is being conducted under an agreement between FDA and the U.S. Agency for International Development (USAID), which funds PQM, operated by USP. Funding for the activity has been provided by the Skoll Global Threats Fund. Other partners include the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC).

“As a development agency, USAID is well-positioned for in-country capacity building such as this,” says Anthony Boni, who leads PQM on USAID’s side through its Office of Health Systems in the Bureau for Global Health. “The presence of infrastructure as well as established relationships with the Ghana FDA provided an excellent platform for the field-testing of CD-3+ in Ghana.”

Since 2008, USAID, through the U.S. President’s Malaria Initiative (PMI) Ghana, has provided USP with US$1,470,000, specifically to strengthen the capacity of the Ghana FDA for the quality assurance of medicines in Ghana.

The tests being conducted in Ghana will evaluate CD-3+ in complementing GPHF’s Minilab™ (thin-layer chromatography) and Thermo Scientific’s TruScan™ (hand-held Raman spectrometer), evaluating counterfeit detection for two commonly used artemisinin-based combination therapies (ACTs) for malaria treatment in Sub-Saharan Africa: artemether + lumefantrine (AR-LU) and artesunate + amodiaquine (AS-AQ).

ENDS

© Scoop Media

 
 
 
 
 
World Headlines

 

UN Health Agency Responds To Ebola Spike

UN health agency responds to Ebola spike by deploying team on border of Guinea and Guinea-Bissau More>>

UN Casts Israel As World's Worst Violator Of Health Rights

Israel's army team of medics recently treated 1,600 victims of the Nepal earthquake. More>>

W Thousands Flee Syria’s Besieged Historic City Of Palmyra

As thousands flee Syria’s besieged historic city of Palmyra, UN refugee agency readies response plan More>>

UN Agency To Halt Housing Allowance For Palestine Refugees

Lack of funds forces UNRWA to suspend cash assistance for housing for Palestinian refugees from Syria in Lebanon. Photo: UNRWA/Shafiq Fahed More>>


Bangkok: International Day Against Homophobia, Transphobia, Biphophia

BMA, UN, embassy representatives, civil society and artists stand united with LGBTI Thais on International Day against Transphobia, Homophobia, and Biphobia (IDAHOT) at Bangkok Art and Culture Centre More>>

Displaced Iraqis Face Difficulties As Fighting Continues

UNHCR is concerned about the processing arrangements in place at the Bzabz bridge – a series of pontoons across the Euphrates River which marks the boundary between Anbar province and the capital, Baghdad. Photo: UNHCR/G. Ohara More>>

UNESCO Chief Condemns Killing Of Bangladeshi Blogger

Director-General of the UN Educational, Scientific and Cultural Organization (UNESCO), Irina Bokova. UN Photo/Devra Berkowitz The head of the United Nations agency with a mandate to defend freedom of expression and press freedom worldwide today voiced ... More>>

Philadelphia: Train Crash

Five people have been confirmed dead and more than 136 people injured after an Amtrak train crashed in Philadelphia today at 9.20pm local time.More>>

UN News: Alarming Surge In Bay Of Bengal Crossings

The number of irregular migrants crossing the Bay of Bengal has almost doubled over the past year amid a dangerous uptick in human smuggling and trafficking across the region, according to a new report from the United Nations refugee agency. More>>

Get More From Scoop

 
 
 
 
 
World
Search Scoop  
 
 
Powered by Vodafone
NZ independent news